Matches in Nanopublications for { ?s ?p "[KRAS mutation rates increased significantly from primary tumors to lymph node metastases and distant metastases within the neuroendocrine negative CRC group (44%, 53%, 64%, respectively, P = 0.042).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- assertion description "[KRAS mutation rates increased significantly from primary tumors to lymph node metastases and distant metastases within the neuroendocrine negative CRC group (44%, 53%, 64%, respectively, P = 0.042).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1231539.RAwQZaDOCN-fkJleRkCaIAsLcrKAdRpdu1FxQIMgclShI130_assertion description "[KRAS mutation rates increased significantly from primary tumors to lymph node metastases and distant metastases within the neuroendocrine negative CRC group (44%, 53%, 64%, respectively, P = 0.042).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1231539.RAwQZaDOCN-fkJleRkCaIAsLcrKAdRpdu1FxQIMgclShI130_provenance.
- NP1231549.RA6rL1RjubtlRgfXn71dWjkF022ALNFfs3_0WwKjFMEkA130_assertion description "[KRAS mutation rates increased significantly from primary tumors to lymph node metastases and distant metastases within the neuroendocrine negative CRC group (44%, 53%, 64%, respectively, P = 0.042).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1231549.RA6rL1RjubtlRgfXn71dWjkF022ALNFfs3_0WwKjFMEkA130_provenance.